Adaptable Commercial Manufacturing Strategies for Your Drug Program

Quotient Sciences balance clinical, CMC, and regulatory requirements to help you accelerate your drug product to commercial manufacture with ease, even in cases where you may be pursuing an accelerated, FDA "Fast Track" or similar development pathway. Read our latest whitepaper, "A Road Map To Expedited Review Pathways," and get started discussing your program.

Nov. 12, 2025

Sponsored by

With a range of drug product formulation and manufacturing services, including small scale commercial batch manufacturing delivered from our US-based CDMO facilities in Philadelphia, PA, Quotient Sciences helps navigate drug programs through all stages of development.

• Solubility enhancement technologies, including spray drying and HME
• Recently expanded capacity for high-containment and potent oral drug products
• Flexibility to support niche commercial products across a range of volumes

If you’re pursuing an accelerated development pathway, choose a CDMO partner that embraces shared success for your product launch with the experience to overcome CMC challenges along the way. Find out how we balance clinical, CMC, and regulatory requirements to help you accelerate your drug product to commercial manufacture with ease.

Read more in our latest whitepaper, "A Road Map To Expedited Review Pathways," and get started discussing your program with us today.